Search research articles
Contact Us
Filters
Showing results (301-310 of 374) with videos related to
Page
of 38
Sort By:
Urological Research
|
August 26, 1999
Expression of bone matrix proteins in urolithiasis model rats
T Yasui, K Fujita, S Sasaki, et al.
Cancer Research
|
August 15, 1995
Anemia-inducing substance from plasma of patients with advanced malignant neoplasms
K Honda, O Ishiko, I Tatsuta, et al.
Journal of Endocrinological Investigation
|
January 27, 2009
Vascular endothelial growth factor in monochorionic twins with twin-twin transfusion syndrome
M Morine, T Nobunaga, T Mizutani, et al.
The Journal of Endocrinology
|
August 15, 2002
Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers
H Uemura, T Yasui, M Kiyokawa, et al.
Journal of Endocrinological Investigation
|
June 15, 2013
Difference in the ratio of high-molecular weight (HMW) to total adiponectin and HMW adiponectin in late post-menopausal women
S Matsui, T Yasui, A Tani, et al.
Journal of Endocrinological Investigation
|
July 25, 2000
Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets
M Kamada, M Irahara, M Maegawa, et al.
Gynecologic and Obstetric Investigation
|
December 1, 2001
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis
M Irahara, H Uemura, T Yasui, et al.
Journal of Neuroendocrinology
|
August 8, 2007
The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats
T Iwasa, T Matsuzaki, M Kiyokawa, et al.
Human & Experimental Toxicology
|
January 18, 2006
Methanol: toxicity of the solvent in a commercial product should also be considered
H Kinoshita, M Nishiguchi, H Ouchi, et al.
Urological Research
|
December 5, 1998
Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney
T Yasui, K Fujita, S Sasaki, et al.
Page
of 38
Search research articles
Search
Showing results (301-310 of 374) with videos related to
Sort By:
Page
of 38
Urological Research
|
August 26, 1999
Expression of bone matrix proteins in urolithiasis model rats
T Yasui, K Fujita, S Sasaki, et al.
Cancer Research
|
August 15, 1995
Anemia-inducing substance from plasma of patients with advanced malignant neoplasms
K Honda, O Ishiko, I Tatsuta, et al.
Journal of Endocrinological Investigation
|
January 27, 2009
Vascular endothelial growth factor in monochorionic twins with twin-twin transfusion syndrome
M Morine, T Nobunaga, T Mizutani, et al.
The Journal of Endocrinology
|
August 15, 2002
Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers
H Uemura, T Yasui, M Kiyokawa, et al.
Journal of Endocrinological Investigation
|
June 15, 2013
Difference in the ratio of high-molecular weight (HMW) to total adiponectin and HMW adiponectin in late post-menopausal women
S Matsui, T Yasui, A Tani, et al.
Journal of Endocrinological Investigation
|
July 25, 2000
Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets
M Kamada, M Irahara, M Maegawa, et al.
Gynecologic and Obstetric Investigation
|
December 1, 2001
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis
M Irahara, H Uemura, T Yasui, et al.
Journal of Neuroendocrinology
|
August 8, 2007
The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats
T Iwasa, T Matsuzaki, M Kiyokawa, et al.
Human & Experimental Toxicology
|
January 18, 2006
Methanol: toxicity of the solvent in a commercial product should also be considered
H Kinoshita, M Nishiguchi, H Ouchi, et al.
Urological Research
|
December 5, 1998
Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney
T Yasui, K Fujita, S Sasaki, et al.
Page
of 38